Literature DB >> 30127927

Tanshinol upregulates the expression of aquaporin 5 in lung tissue of rats with sepsis.

Jianfeng Xu1,2, Lei Yang1,3, Liang Dong1.   

Abstract

Aquaporin 5 (AQP-5) is a water channel protein that is closely associated with non-small cell lung cancer tissues. The present study aimed to investigate the mechanism of tanshinol treatment on AQP-5 in the lung tissue of rats with sepsis. Animals in a rat sepsis model were randomly divided into six groups including blank control (ctrl), sham operation (SO), model (sepsis), low dose tanshinol (5 mg/kg/day; Tan-L), moderate dose tanshinol (10 mg/kg/day; Tan-M) and high dose tanshinol (20 mg/kg/day; Tan-H) groups. After 7 days of administration, the expression level of AQP-5 mRNA was detected by reverse transcription-quantitative polymerase chain reaction. The levels of interleukin-6 (IL-6) and tumor necrosis factor α (TNF-α) were measured by ELISA. Hematoxylin and eosin staining was used for histopathological observation. The expression levels of AQP-5, P38 and phosphorylated (P)-P38 protein in lung tissues were detected by western blot analysis. The expression levels of AQP-5 in the sepsis group were significantly decreased compared with those in ctrl and SO groups (P<0.01), while the levels of TNF-α, IL-6 and p-P38 were significantly increased in sepsis group compared with those in ctrl and SO groups (P<0.01). Following tanshinol intervention, the expression levels of AQP-5 were significantly increased, while the levels of TNF-α, IL-6 and p-P38 were decreased compared with those in sepsis group. Tanshinol may upregulate the expression of AQP-5 by inhibiting the inflammatory cytokines and phosphorylation of P38, therefore protecting the lung tissue of rats with sepsis.

Entities:  

Keywords:  aquaporins 5; inflammatory response; lung tissue; sepsis; tanshinol

Year:  2018        PMID: 30127927      PMCID: PMC6096120          DOI: 10.3892/ol.2018.9026

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  32 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 2.  Mobilization in severe sepsis: an integrative review.

Authors:  Sushant Govindan; Theodore J Iwashyna; Andrew Odden; Scott A Flanders; Vineet Chopra
Journal:  J Hosp Med       Date:  2015-01       Impact factor: 2.960

3.  Hyperbaric oxygen therapy palliates lipopolysaccharide-induced acute lung injury in rats by upregulating AQP1 and AQP5 expression.

Authors:  Guang Han; Ling Ma; Yao Guo; Lu Li; Dan Li; Hongtao Liu
Journal:  Exp Lung Res       Date:  2015-08-28       Impact factor: 2.459

4.  Activation of p38 stress-activated protein kinase during Rickettsia rickettsii infection of human endothelial cells: role in the induction of chemokine response.

Authors:  Elena Rydkina; David J Silverman; Sanjeev K Sahni
Journal:  Cell Microbiol       Date:  2005-10       Impact factor: 3.715

Review 5.  2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference.

Authors:  Mitchell M Levy; Mitchell P Fink; John C Marshall; Edward Abraham; Derek Angus; Deborah Cook; Jonathan Cohen; Steven M Opal; Jean-Louis Vincent; Graham Ramsay
Journal:  Crit Care Med       Date:  2003-04       Impact factor: 7.598

Review 6.  [Oxidative stress related diseases and biopyrrins].

Authors:  Izuru Shioji
Journal:  Rinsho Byori       Date:  2005-02

7.  Deletion of aquaporin 5 aggravates acute lung injury induced by Pseudomonas aeruginosa.

Authors:  Zi-Qiang Zhang; Yuan-Lin Song; Zhi-Hong Chen; Yao Shen; Chun-Xue Bai
Journal:  J Trauma       Date:  2011-11

8.  A novel compound DSC suppresses lipopolysaccharide-induced inflammatory responses by inhibition of Akt/NF-κB signalling in macrophages.

Authors:  Xin-Hua Liu; Li-Long Pan; Yao-Ling Jia; Dan Wu; Qing-Hui Xiong; Yang Wang; Yi-Zhun Zhu
Journal:  Eur J Pharmacol       Date:  2013-01-23       Impact factor: 4.432

Review 9.  Aquaporins: important but elusive drug targets.

Authors:  Alan S Verkman; Marc O Anderson; Marios C Papadopoulos
Journal:  Nat Rev Drug Discov       Date:  2014-03-14       Impact factor: 84.694

Review 10.  Aquaporins in Salivary Glands: From Basic Research to Clinical Applications.

Authors:  Christine Delporte; Angélic Bryla; Jason Perret
Journal:  Int J Mol Sci       Date:  2016-01-27       Impact factor: 5.923

View more
  4 in total

Review 1.  Role of Aquaporins in Inflammation-a Scientific Curation.

Authors:  Lezy Flora Mariajoseph-Antony; Arun Kannan; Antojenifer Panneerselvam; Chithra Loganathan; Esaki M Shankar; Kumarasamy Anbarasu; Chidambaram Prahalathan
Journal:  Inflammation       Date:  2020-10       Impact factor: 4.092

Review 2.  Aquaporins in lung health and disease: Emerging roles, regulation, and clinical implications.

Authors:  Ekta Yadav; Niket Yadav; Ariel Hus; Jagjit S Yadav
Journal:  Respir Med       Date:  2020-10-17       Impact factor: 3.415

3.  Novel assays for quality evaluation of XueBiJing: Quality variability of a Chinese herbal injection for sepsis management.

Authors:  Xuan Yu; Wei Niu; Ya-Ya Wang; Olajide E Olaleye; Jia-Nan Wang; Meng-Yuan Duan; Jun-Ling Yang; Rong-Rong He; Zi-Xuan Chu; Kai Dong; Gui-Ping Zhang; Chang-Xiao Liu; Chen Cheng; Chuan Li
Journal:  J Pharm Anal       Date:  2022-01-26

4.  Could aquaporin modulators be employed as prospective drugs for COVID-19 related pulmonary comorbidity?

Authors:  Lezy Flora Mariajoseph-Antony; Arun Kannan; Antojenifer Panneerselvam; Chithra Loganathan; Kumarasamy Anbarasu; Chidambaram Prahalathan
Journal:  Med Hypotheses       Date:  2020-08-17       Impact factor: 1.538

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.